FDA Investigator Wendy G Tan, PhD

Wendy G Tan, PhD has inspections in 7 countries as of 17 Oct 2023. Wendy G Tan, PhD has collaborated with a combinined 5100 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
19
Last Inspection Date:
17 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France, Germany, Sweden, Israel, China, Singapore
Co-Investigator(s):
Adaliz Santaliz Cruz, Adam R Cooke, Alan A Rivera, Alan M Barker, Alice C Silva, Alice S Tsao, Alicia M Mozzachio, Alifiya H Ghadiali, Amy Devlin, PhD, Anders W Evenson, Andrea George, PhD, Andrew J Barrowcliff, Angela E Glenn, Anita Narula, PhD, Ann L Demarco, Anna Lazar, Arie C Menachem, Arlene M Badillo, Ashley N Queen, PhD, Barbara Janine Breithaupt, Barbara M Frazier, Bijoy Panicker, Bill Tacket, Jr, Bo Chi, PhD, Brian D Nicholson, Brian J Ryan, Brittani N Franklin, Calvin B Koerner, Cameron J Smith, Carrie Ann Plucinski, Cary Greene, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charanjeet Jassal, Charles L Zhou, Charles Yuanchia Kuo, PhD, Cheryl A Clausen, Christina A Miller, Christopher D Leach, Christopher Downey, PhD, Christopher R Czajka, Christopher S Keating, Colleen Thomas, PhD, Daniel B Arrecis, Daniel J Lahar, Daniel Lagasse, Dariusz Galezowski, Daryl A Dewoskin, David M Beltran, Dawn E Barkans, Denise M Digiulio, Dennis Cantellops Paite, Diane L Raccasi, Djamila Harouaka, Donald C Obenhuber, PhD, Donna A Katz, Douglas A Campbell, Douglas C Kovacs, Dov Pluznik, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Eliezar Ramos, Ephrem Hunde, PhD, Eric L Dong, BS, Erika E Englund, PhD, Erika V Butler, Erin L Nagel, Esther C Broner, PhD, Felix Maldonado, Frank Wackes, Gene D Arcy, Gerard Pde Leon, Gerardo Z Vazquez, Gregory Price, Gretchen M Laws, Hamet M Toure, PharmD MPH, Harry J Brewer, Heika R Tait, Heika Tait, Helen B Ricalde, Ivis Lnegron Torres, Jacek Cieslak, PhD, James A Lane, James D Bridges, James L Dunnie, Jr, Janet L Bowen, Jason F Chancey, Jazmine N Brown, Jean A Peeples, Jennifer C Adams, Jennifer C Johnson, Jennifer L Huntington, Jennifer Lalama, Jennifer M Gogley, Jerri Baker, Jie He, Joanne E King, John A Podsadowski, Johnna L Bleem, Jonathan G Swoboda, Jorge L Guadalupe, Jorge L Lajara, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Melendez, Jose O Hernandez, Jose Ohernandez Guzman, Jose R Lopez, Jose Velez, Joseph J Vannelli, Joshua P Wireman, Juandria V Williams, Justin A Boyd, Kalavati Suvarna, PhD, Karen G Hirshfield, Karen L Kosar, Katherine E Jacobitz, Kathleen R Jones, PhD, Kathy E Craven, Kathy E Noe, Kenneth O Gee, PhD, Kevin A Gonzalez, Kevin D Kallander, Kham Phommachanh, Kim M Downing, Kimberley A Hoefen, Lane Christensen, PhD, Lane V Christensen, PhD, Latorie S Jones, Latoya A Griffith, Lauren N Howard, Lauren N Smith, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Mark A Jimenez, RN, LCDR Michael H Tollon, Leiyun Boone, PhD, Leon L Law, Liatte Kreuger, PharmD, Libia M Lugo, Linda M Sacco, Lindsey M Schwierjohann, Lisa R Hilliar, Lisa Sg Shelton, LT Rafael Gonzalez, Maan S Abduldayem, Mabany Lizardi, Marcellinus D Dordunoo, Maria A Ruttell, Maria G Gutierrez Hoffman, Maria Gutierrez Hoffman, PhD, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Maria Pkelly Doggett, MBA, Marian E Ramirez, Marie Bbuen Bigornia, Marion Michaelis, Marisa E Stock, Marjorie A Shapiro, PhD, Mark W Babbitt, Martin R Vowell, Mary E Farbman, PhD, Matthew D Schnittker, Maxwell Van Tassell, PhD, Merry Christie, PhD, Michael A Charles, Michael A Moses, PhD, Michael D Smedley, Michael E Maselli, Michael Shanks, MS, Michael W Burd, Michele L Glendenning, Michelle Y Clark Stuart, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Mindy M Chou, Mizanne E Lewis, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Muna Algharibeh, Myriam M Sosa, Neal L Adams, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas L Paulin, Nicholas Obiri, PhD, Nicole A Lloyd, Nicole E Knowlton, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pal S Mayasandra, Parul M Patel, Patricia Fhughes Troost, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Figarole, Jr, Paul Mouris, Paul Z Balcer, Paula A Trost, Peng Zhou, Prajakta A Varadkar, Qiao Y Bobo, Rajiv R Srivastava, Ralph A Erickson, Ramesh Potla, PhD, Ramesh Sood, Ramon A Hernandez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Robert C Coleman, Robert C Steyert, Robert Darius, Roger F Zabinski, Ronald T Weber, Rong Wang, PhD, Rose Xu, Russell J Glapion, Russell K Riley, Ruth Moore, PhD, Saied A Asbagh, Sangeeta M Khurana, PhD, Santos E Camara, Seneca D Toms, Shana L Williams, Sharon K Pederson, Sharon K Thoma, PharmD, Simone E Pitts, Sneha S Patel, Song Y Lavalais, Sony Mathews, Sonya M Edmonds, Steven C Madzo, Steven Fong, MS, PhD, Steven M Weinman, Susan P Bruederle, Susan W Ciani, Susanna E Ford, Analyst, Tamara L Ely, Tara R Gooen, Thomas J Arista, Thomas S Arista, Thuy T Nguyen, LCDR, Tiffani D Wilson, Timothy Wadkin, PhD, Tracy Denison, PhD, Truong Xuan Nguyen (Andy), Vaishali J Patel, Veronica Fuentes, MS, Vilmary Negron Rodriguez, Viviana Matta, Wayne E Seifert, Wendy Tam, William J Leonard, Yasamin Ameri, Ying Xin Fan, PhD, Yong Hu, Yuan Chia Kuo, Yvonne E Lozano, Zachary L Miller, Zachary L Stamm, Zakaria Wahba, Zedong Dong, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Wendy G Tan, PhD's Documents

Publish Date Document Type Title
February, 2020 FDA 483 Amgen Manufacturing Ltd - Form 483, 2020-02-27
February, 2020 FDA 483 Response Amgen Manufacturing Ltd - Form 483R, 2020-03-18
January, 2020 FDA 483 Xellia Pharmaceuticals USA LLC - Form 483, 2020-01-31
September, 2022 FDA 483 Lilly France - Form 483, 2022-09-29
January, 2022 FDA 483 Kashiv BioSciences, LLC - Form 483, 2022-01-14
March, 2022 FDA 483 Woodstock Sterile Solutions, Inc - Form 483, 2022-03-03
March, 2023 FDA 483 Rentschler Biopharma Inc. - Form 483, 2023-03-22
December, 2021 FDA 483 AstraZeneca AB - Form 483, 2021-12-08
February, 2020 EIR Amgen Manufacturing Ltd - EIR, 2020-03-17
June, 2022 FDA 483 SEAGEN INC. - Form 483, 2022-06-10
March, 2022 EIR Woodstock Sterile Solutions, Inc - EIR, 2022-03-03
August, 2022 FDA 483 Biogen U.S. Corporation - Form 483, 2022-08-26
March, 2023 FDA 483 Rentschler Biopharma SE - Form 483, 2023-03-07
May, 2017 EIR Bausch & Lomb Incorporated - EIR, 2017-05-26
May, 2023 FDA 483 Suzhou Union Biopharm Co., Ltd. - Form 483, 2023-05-26
August, 2022 FDA 483 Roche Singapore Technical Operations Pte. Ltd. - Form 483, 2022-08-01
February, 2017 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2017-02-01
May, 2017 FDA 483 Bausch & Lomb Incorporated - Form 483, 2017-05-26
March, 2023 FDA 483 Rentschler Biopharma Inc. - Form 483, 2023-03-22
January, 2020 EIR Xellia Pharmaceuticals USA LLC - EIR, 2020-01-31
February, 2017 EIR Fresenius Kabi USA, LLC - EIR, 2017-02-01
November, 2017 FDA 483 Rafa Laboratories Ltd. - Form 483, 2017-11-13
November, 2023 FDA 483 Catalent Indiana, LLC - Form 483, 2023-11-15
December, 2023 FDA 483 Human Genome Sciences, Inc. - Form 483, 2023-12-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more